Dr. Ulrich Zimmermann

Radiation oncologist · Cleveland Clinic · United States (US) · Oncology

Tier 2STK-0013GoodOwner MSL MTMei Tanaka

Data minimisation

Consent status: Recorded. The name shown may be a pseudonym. Contact details, personal identifiers and remuneration fields are hidden for your role; only scientific-profile fields needed for engagement planning are displayed.

Specialty: Thoracic oncology
Disease interests: SCLC, NSCLC
Scientific interests: irAE managementElderly patients
Engagement preference: Virtual
Advisory boards: 0
Publications: 41
Source system: Veeva CRM
Data quality: Good

Engagement plan

Cadence target for Tier 2: 2 per year (assumption)

Last engaged: 24 May 2026 (114 days ago)
Next planned contact: 23 Nov 2026
Last 6 months vs target: 100%
2 of 1 expected engagements

Insights from this stakeholder (0)

No insights captured from engagements with this stakeholder.

Engagement history (2)

All engagements including drafts, newest first

Date	Type	Format	MSL	Product	Topics	Insights	Flags	Status
24 May 2026	Scientific exchange	In person	Mei Tanaka	Vantrexa	Brain-metastasis subgroup dataDuration of response	0	—	Reviewed	ENG-0114
17 Mar 2026	Advisory board	In person	Mei Tanaka	Vantrexa	Chemotherapy-free first linePD-L1 testing turnaround	0	—	Reviewed	ENG-0070

Timeline

24 May 2026
Scientific exchange
Brain-metastasis subgroup data, Duration of response
17 Mar 2026
Advisory board
Chemotherapy-free first line, PD-L1 testing turnaround

Related stakeholders (2)

Cleveland Clinic

Dr. Paola Bauer
Oncology pharmacist
Tier 3
Dr. Noor Tanaka
Allergist
Tier 3